FREE Account Opening + No Clearing Fees
Loading...

Alkem Laboratories IPO vs Healthcare Global IPO

Comparision between Alkem Laboratories IPO and Healthcare Global IPO.

IPO Details

Alkem Laboratories IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Healthcare Global IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Alkem Laboratories IPO is up to ₹1,349.61 Cr whereas the issue size of the Healthcare Global IPO is up to ₹649.64 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of Healthcare Global IPO is ₹218.00 per share.

  Alkem Laboratories IPO Healthcare Global IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹1,020.00 per share ₹205.00 per share
Issue Price (Upper) ₹1,050.00 per share ₹218.00 per share
Issue Price (Final) ₹1,050.00 per share ₹218.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 14 shares 65 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 1,28,53,442 shares 2,98,00,000 shares
Issue Size Total (Amount) up to ₹1,349.61 Cr up to ₹649.64 Cr

IPO Timetable

Alkem Laboratories IPO opens on Dec 08, 2015, while Healthcare Global IPO opens on Mar 16, 2016. The closing date of Alkem Laboratories IPO and Healthcare Global IPO is Dec 10, 2015, and Mar 18, 2016, respectively.

  Alkem Laboratories IPO Healthcare Global IPO
Anchor Bid Date
Issue Open Dec 08, 2015 Mar 16, 2016
Issue Close Dec 10, 2015 Mar 18, 2016
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Alkem Laboratories IPO P/E ratio is , as compared to Healthcare Global IPO P/E ratio of .

  Alkem Laboratories IPO Healthcare Global IPO
Financial
ParticularsFor the year/period ended (in Rs. Million)
31 Mar 1531 Mar 1431 Mar 1331 Mar 12
Total Income33,595.2028,395.8024,690.1020,640.10
Profit After Tax (PAT)4,370.904,402.004,667.804,318.10

Particulars

For the year/period ended (in Rs. Million)
31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12 31-Mar-11
Total Liabilities 6,895.42 6,138.21 6,436.40 4,362.63 3,203.63
Total Assets 6,895.42 6,138.21 6,436.40 4,362.63 3,203.63
Total Revenue 4,244.41 3,525.94 2,939.52 2,051.67 1,601.43
Profit After Tax (PAT) (23.66) (394.98) (71.58) (40.02) 34.40
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Alkem Laboratories IPO retail investors (RII) are offered 43,94,086 shares while in Healthcare Global IPO retail investors are offered 43,94,086 shares. Qualified institutional buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 89,40,000 shares in Healthcare Global IPO.

  Alkem Laboratories IPO Healthcare Global IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 25,10,906 shares 89,40,000 shares
NII 18,83,179 shares 44,70,000 shares
RII 43,94,086 shares 29,80,000 shares
Employee 2,98,913 shares
Others
Total 90,87,084 shares 1,63,90,000 shares

Bids Received (Subscription)

Alkem Laboratories IPO subscribed 44.29x in total, whereas Healthcare Global IPO subscribed 1.56x.

  Alkem Laboratories IPO Healthcare Global IPO
QIB (times) 57.19x 2.36x
NII (times) 129.96x 0.43x
Big NII (times)
Small NII (times)
RII (times) 3.17x 0.83x
Employee (times) 0.67x
Other (times)
Total (times) 44.29x 1.56x

Comments

Add a public comment...